| Name | Title | Contact Details |
|---|---|---|
Jessica Crosbie |
VP, Global Insights and Analytics Oncology Business Unit | Profile |
Guillaume Pasquier |
VP, Head of R&D Digital & Information Technology | Profile |
Kimberly Holliday |
VP, Head of Strategic Planning & Transformation | Profile |
Giuseppe Cognetti |
Sr. Director, Head PharmSci Technology | Profile |
Enrico Maldari |
Director, U.S. Regional Security and Crisis Management Advisor | Profile |
US Micron is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson`s, Alzheimer`s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
Hemagen Diagnostics is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Oxis International, Inc. has formed and provided initial financing to support the activities of its wholly owned subsidiary, Oxis Biotech, Inc. The parent company, Oxis International is engaged in the research, development and sale of products to counteract oxidative stress and inflammation. Oxis Biotech is focused on the acquisition of cannabis related intellectual properties and commercialization of therapies developed from the intellectual properties to treat certain diseases.
JHP Pharmaceutical is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.